COMPOUNDS USEFUL AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:US20140179699A1
公开(公告)日:2014-06-26
The present invention relates to compounds useful as inhibitors of indoleamine 2,3-dioxygenase (IDO). The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications.
The compounds of this invention have formula I-A:
wherein the variables are as defined herein.
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
申请人:Vertex Pharmaceuticals Incorporated
公开号:US09073875B2
公开(公告)日:2015-07-07
The present invention relates to compounds useful as inhibitors of indoleamine 2,3-dioxygenase (IDO). The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications. The compounds of this invention have formula I-A:
wherein the variables are as defined herein.
[EN] COMPOUNDS USEFUL AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE<br/>[FR] COMPOSÉS UTILES COMME INHIBITEURS DE L'INDOLÉAMINE 2,3-DIOXYGÉNASE
申请人:VERTEX PHARMA
公开号:WO2014081689A1
公开(公告)日:2014-05-30
The present invention relates to compounds useful as inhibitors of indoleamine 2,3-dioxygenase (IDO). The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications.. The compounds of this invention have formula I-A; wherein the variables are as defined herein.